Subscribe
shutterstock_1397823521_pavel_kapysh
Pavel Kapysh / Shutterstock.com
27 September 2022BiotechnologyStaff Writer

Bio-Techne takes patent dispute to UK

The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
LES 2015: ‘Much unrest’ in molecular diagnostics area, argues Roche
28 October 2015   There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.
Americas
Pfizer acquires AstraZeneca’s small molecule anti-infective business
25 August 2016   Pharmaceutical company Pfizer has acquired AstraZeneca’s small molecule anti-infective business.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Biotechnology
LES 2015: ‘Much unrest’ in molecular diagnostics area, argues Roche
28 October 2015   There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.
Americas
Pfizer acquires AstraZeneca’s small molecule anti-infective business
25 August 2016   Pharmaceutical company Pfizer has acquired AstraZeneca’s small molecule anti-infective business.

More on this story

Biotechnology
LES 2015: ‘Much unrest’ in molecular diagnostics area, argues Roche
28 October 2015   There is “clearly a lot of unrest” in the patent law on molecular diagnostics, according to the head of licensing at Roche Diagnostics.
Americas
Pfizer acquires AstraZeneca’s small molecule anti-infective business
25 August 2016   Pharmaceutical company Pfizer has acquired AstraZeneca’s small molecule anti-infective business.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott